Skip to main content
Menu

AlphaLISA SureFire Biotin-Free Human AR / BRD4 Ternary Complex Detection Kit, 100 Assay Points

The AlphaLISA™ SureFire® Biotin-Free Human AR / BRD4 Ternary Complex assay is a sandwich immunoassay for quantitative detection of the AR / BRD4 ternary complex in cellular lysates using Alpha Technology.

Feature Specification
Application Cell Signaling
Protocol Time 2h at RT
Sample Volume 30 µL

The AlphaLISA™ SureFire® Biotin-Free Human AR / BRD4 Ternary Complex assay is a sandwich immunoassay for quantitative detection of the AR / BRD4 ternary complex in cellular lysates using Alpha Technology.

Product variants
Compare all
Remove all
Add to compare Add to compare
Remove
Unit Size: 100 Assay Points
Part #:
ASBF-CARBR4-A-HV
List price
USD 737.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 500 Assay Points
Part #:
ASBF-CARBR4-A500
List price
USD 2,490.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 10,000 Assay Points
Part #:
ASBF-CARBR4-A10K
List price
USD 14,982.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 50,000 Assay Points
Part #:
ASBF-CARBR4-A50K
List price
USD 47,624.00
Your price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Loading...

Overview

The AR/BRD4 ternary complex represents a transcriptional co-regulatory assembly in which the androgen receptor cooperates with Bromodomain and Extra-Terminal domain protein 4 (BRD4) and Mediator components to drive androgen-responsive gene expression in prostate cancer. BRD4 is recruited to AR-bound enhancers and super-enhancers through recognition of acetylated histone marks, where it facilitates RNA Pol II pause release and transcriptional elongation of AR target genes including KLK3 (PSA), TMPRSS2, and MYC. The interaction between AR and BRD4 at chromatin represents a convergence of androgen signaling and epigenetic regulation, and co-occupancy of AR and BRD4 at super-enhancers is associated with transcriptional amplification of oncogenic programs in CRPC. BET bromodomain inhibitors such as JQ1 and OTX015 disrupt BRD4 recruitment to AR-regulated loci, suppressing AR transcriptional output even in the context of AR-V7 expression or LBD mutations, providing a rationale for BET inhibition as a strategy to overcome antiandrogen resistance. Detection of the AR/BRD4 ternary complex enables characterization of this epigenetic co-regulatory axis and is relevant to studies of transcriptional addiction and therapeutic vulnerability in advanced prostate cancer. In addition, RIPTAC (Regulated Induced Proximity Targeting Chimera) is a novel therapeutic strategy designed to exploit protein–protein interactions, such as the AR–BRD4 complex, to reduce oncogenic transcription and induce selective cell toxicity.

The AlphaLISA SureFire Biotin-Free Human AR / BRD4 Ternary Complex Detection Kit is a sandwich immunoassay for the quantitative detection of AR / BRD4 ternary complex in cellular lysates, using Alpha Technology.

Formats:

  • The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
  • The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
  • The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
  • The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Biotin Free kits are compatible with:

  • Cell and tissue lysates
  • Antibody modulators
  • Biotherapeutic antibodies
  • Biotin rich samples

AlphaLISA SureFire Biotin Free kits can be used for:

  • Cellular kinase assays
  • Receptor activation studies
  • High-throughput screening for preclinical studies

How it works

AlphaLISA SureFire Ultra Biotin Free protein complex detection assay principle

The AlphaLISA SureFire Ultra Biotin Free complex assay measures cellular protein-protein interactions (PPI) in a biological sample (e.g. cell lysate).

The assay uses two antibodies that specifically recognize Protein 1 and Protein 2, respectively. AlphaLISA assays require two types of beads: Donor Beads and Acceptor Beads. The Acceptor Beads are coated with the proprietary CaptSure™ reagent, which specifically binds the first assay antibody labeled with a CaptSure tag. The Donor Beads are coated with the proprietary CaptSure3 reagent, which captures the second detection antibody labeled with a CaptSure3 tag. In the presence of the protein complex, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of PPI present in the sample.

Complex detection AlphaLISA SureFire Ultra Biotin Free assay principle

 

AlphaLISA SureFire Ultra Biotin Free complex detection two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well Optiplate plate before the addition of complex AlphaLISA SureFire Ultra Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

2 plates assay protocol AlphaLISA Surefire Ultra Biotin Free Phospho assay.jpg

AlphaLISA SureFire Ultra Biotin Free protein complex detection one-plate assay protocol

Detection of the protein complex with AlphaLISA SureFire Ultra Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire Ultra Biotin Free assay quality.

Phospho-AlphaLISA SureFire Ultra Biotin Free one-plate assay protocol

Assay validation

Induction of AR/BRD4 Ternary Complex following RIPTAC treatment

LNCaP and 22Rv1 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with 200 nM of AR/BRD4 RIPTAC for the indicated time points.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). AR/BRD4 Ternary Complex levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (approximately 12,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, treatment with AR/BDR4 RIPTAC compound significantly induced AR/BRD4 Ternary Complex formation.

Pharmacological validation (activator) of AR/BRD4 Ternary Complex assay

AR/BRD4 Ternary Complex is stable up to 72 hours following treatment

LNCaP cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with 100 nM of AR/BRD4 RIPTAC for 24, 48 and 72 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). AR/BRD4 Ternary Complex levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (approximately 12,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

The AR/BDR4 Ternary Complex was stable up to 72 hours after treatment. ERK Total levels remained unchanged (data not shown).

Pharmacological validation (activator) of AR/BRD4 assay

Induction of AR/BRD4 Ternary Complex in a dose-dependent manner

LNCaP and 22Rv1 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with increasing concentrations of AR/BRD4 RIPTAC for 4 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). AR/BRD4 Ternary Complex levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (approximately 12,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, treatment with AR/BDR4 RIPTAC compound significantly induced AR/BRD4 Ternary Complex formation while ERK Total levels remained unchanged.

Pharmacological validation (activator) of AR/BRD4 assay

Assay sensitivity

Assay sensitivity - cell lysate dilution

Cell lysate was prepared from LNCaP cells seeded in T175 flasks and cultured to confluence at 37°C, 5% CO2.Cells were then treated with 100 nM AR/BRD4 RIPTAC for 4 hours and lysed in 4 mL of Lysis Buffer for 10 minutes at RT with shaking.

Lysates were serially diluted in Lysis Buffer and AR/BRD4 Ternary Complex levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Approximate number of cells/datapoint is indicated on the graph. The assay can detect AR/BRD4 Ternary Complex down to 1,000 cells. Assay background is represented with a dotted line.

Assay sensitivity

Specifications

Application
Cell Signaling
Automation Compatible
Yes
Brand
AlphaLISA SureFire Biotin-Free
Detection Modality
Alpha
Product Group
Kit
Protocol Time
2h at RT
Sample Volume
30 µL
Shipping Conditions
Shipped in Blue Ice
Target
AR / BRD4
Target Class
Phosphoproteins
Target Species
Human
Technology
Alpha
Therapeutic Area
Oncology
Unit Size
100 Assay Points

Resources

Are you looking for resources, click on the resource type to explore further.

1-4 of 4 Resources
Brochure Icon
Brochure
Alpha assays and reagents catalog

Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...

Guide Icon
Guide
AlphaLISA SureFire Ultra: the ultimate guide for successful experiments

The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay

Several biological processes are regulated by...

Brochure Icon
Brochure
Alpha SureFire Ultra no-wash immunoassay catalog

Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...

Brochure Icon
Brochure
Species compatibility for HTRF, AlphaLISA SureFire Ultra and Alpha SureFire Ultra Multiplex assays

This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...

Loading...

Revvity AI Assistant Beta

Scroll Icon